Congrats on following up on HLYK. Been following this company for a couple years now. When the momentum kicks in the climb upward will last for quite a while and these prices of .20 and less will be laughable. I envision current NeoGenomic investors that invested with CEO Dent years ago to invest with HLYK as well as the physicians and other medical personnel find out about HLYK.
As far as IFRX, I am very intrigued with that company as well and would rather miss the first 10-20% before I reinvest again to make sure the trials are satisfactory.
News 
Market Data 
Discover 
